BioCentury
ARTICLE | Clinical News

Vivolux preclinical data

March 3, 2014 8:00 AM UTC

In a mouse xenograft model of colorectal cancer, IV 16 mg/kg VLX600 given every 3 days for 16 days significantly inhibited tumor growth vs. vehicle-treated controls (p=0.02). VLX600-treated mice showe...